|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-7-18
|
|
pubmed:abstractText |
To determine whether 500,000 KIU aprotinin is effective to reduce blood loss in coronary artery bypass grafting (CABG) and to evaluate the effects of this regimen on hematologic parameters.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0886-0440
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
336-41
|
|
pubmed:meshHeading |
pubmed-meshheading:16846409-Adult,
pubmed-meshheading:16846409-Aprotinin,
pubmed-meshheading:16846409-Biological Markers,
pubmed-meshheading:16846409-Blood Loss, Surgical,
pubmed-meshheading:16846409-Blood Transfusion,
pubmed-meshheading:16846409-Complement Activation,
pubmed-meshheading:16846409-Coronary Artery Bypass,
pubmed-meshheading:16846409-Coronary Disease,
pubmed-meshheading:16846409-Dose-Response Relationship, Drug,
pubmed-meshheading:16846409-Female,
pubmed-meshheading:16846409-Fibrinolysis,
pubmed-meshheading:16846409-Humans,
pubmed-meshheading:16846409-Male,
pubmed-meshheading:16846409-Middle Aged,
pubmed-meshheading:16846409-Perioperative Care,
pubmed-meshheading:16846409-Serine Proteinase Inhibitors,
pubmed-meshheading:16846409-Treatment Outcome
|
|
pubmed:articleTitle |
Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
|
|
pubmed:affiliation |
Cardiovascular Surgery Clinic, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
